Notice of Correction to Expiration Date, Funds Available and Award Budget for RFA-FD-12-020 Effect of Physiocochemical Properties of Opthalmic Formulations on Ocular Bioavailability (U01)


Notice Number: NOT-FD-12-008

Key Dates

Release Date: May 4, 2012

Related Notices

RFA-FD-12-020

Issued by

U.S. Food and Drug Administration (FDA)

Purpose

The purpose of this Notice is to correct the Expiration Date, Funds Available and Award Budget for RFA-FD-12-020.

Now Reads:

Expiration Date

June 1, 2012


Should Read:

Expiration Date

June 23, 2012


Now Reads:

Funds Available

The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications received. FDA/CDER intends to commit up to $400,000 in FY 2012.

It is anticipated that one (1) award will be made, not to exceed $400,000 in total costs (direct plus indirect).

Award Budget

The amount of financial assistance requested from FDA may not exceed $400,000.


Should Read:

Funds Available

The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications received. FDA/CDER intends to commit up to $500,000 in FY 2012.

It is anticipated that one (1) award will be made, not to exceed $500,000 in total costs (direct plus indirect).

Award Budget

The amount of financial assistance requested from FDA may not exceed $500,000.


Inquiries

Please direct all inquiries to:

Lisa Ko
Grants Management Specialist
U.S. Food and Drug Administration
Office of Acquisition and Grants Services
5630 Fishers Lane Room 1096
Rockville, MD 20857
TEL: 301-827-5095
FAX: 301-827-1044
EMAIL: Lisa.Ko@fda.hhs.gov